There is currently no text in this page. You can search for this page title in other pages, or search the related logs, but you do not have permission to create this page.
Category:Bristol-Myers Squibb Company
Appearance
Pages in category "Bristol-Myers Squibb Company"
The following 35 pages are in this category, out of 35 total.
2
- 20240009081. COMBINATORIAL DRUG DELIVERY DEVICE simplified abstract (Bristol-Myers Squibb Company)
- 20250152708. Compositions Comp (Bristol-Myers Squibb Company)
- 20250152708. Compositions Comp (Bristol-Myers Squibb)
- 20250154132. Crystal Form Of 6 (Bristol-Myers Squibb Company)
- 20250154148. Kras Inhibitors (Bristol-Myers Squibb Company)
- 20250154257. Treatment Of Lung (Bristol-Myers Squibb Company)
- 20250154258. Methods Of Treati (Bristol-Myers Squibb Company)
- 20250154274. Use Of Anti-pd-1 (Bristol-Myers Squibb Company)
- 20250163004. Substituted Heter (Bristol-Myers Squibb)
- 20250163025. Compounds (Bristol-Myers Squibb)
- 20250163046. Kras Inhibitors (Bristol-Myers Squibb)
- 20250163054. Substituted Bicyc (Bristol-Myers Squibb)
- 20250163104. Macrocyclic Immun (Bristol-Myers Squibb)
- 20250163152. Compositions Comp (Bristol-Myers Squibb)
- 20250163155. Combination (Bristol-Myers Squibb)
- 20250171538. Tim-3 Antagonists (Bristol-Myers Squibb)
- 20250171732. Methods Produc (Bristol-Myers Squibb)
- 20250174357. Machine-learning (Bristol-Myers Squibb)
- 20250177363. Substituted Imida (Bristol-Myers Squibb)
- 20250179140. Interleukin-2/int (Bristol-Myers Squibb)
- 20250179174. Combination Thera (Bristol-Myers Squibb)
- 20250188152. Transient Express (Bristol-Myers Squibb)
- 20250188463. Antisense Oligonu (Bristol-Myers Squibb)
- 20250205334. Antibody Composit (Bristol-Myers Squibb)
- 20250206775. Methods Isolat (Bristol-Myers Squibb)
- 20250213548. Pharmaceutical Co (Bristol-Myers Squibb)
- 20250215076. Combination Thera (Bristol-Myers Squibb)
- 20250215087. Combination Thera (Bristol-Myers Squibb)
- 20250230144. Quinazolines As P (Bristol-Myers Squibb)
- 20250230251. Antibodies Target (Bristol-Myers Squibb)
B
- Blockchain patent applications on 22nd Mar 2024
- Blockchain patent applications on April 4th, 2024
- Blockchain patent applications on January 11th, 2024
- Blockchain patent applications on March 21st, 2024
- Bristol-Myers Squibb Company (20250152708). COMPOSITIONS COMPRISING AN ANTI-LAG-3 ANTIBODY OR AN ANTI-LAG-3 ANTIBODY AND AN ANTI-PD-1 OR ANTI-PD-L1 ANTIBODY